Table: Daito -Q1 group results

Daito Pharmaceutical

10/10/2025 08:30

Oct 10 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2025        Aug 31, 2024     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.01               12.68            52.50    
                 (+2.6 pct)          (+4.1 pct)       (+3.7 pct)  
  Operating        998 mln             849 mln            3.00    
                 (+17.6 pct)         (-21.4 pct)      (+14.5 pct) 
  Recurring          1.05              983 mln            3.00    
                 (+7.1 pct)          (-10.0 pct)      (+10.9 pct) 
  Net              696 mln             618 mln            2.30    
                 (+12.8 pct)         (-9.6 pct)       (+20.5 pct) 
  EPS             23.24 yen           20.21 yen        76.70 yen  
  Ann Div                             70.00 yen        40.00 yen  
  -Q2 div                             35.00 yen        20.00 yen  
  -Q4 div                             35.00 yen        20.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T